Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
André Eiras dos Santos
AddedFeb 19, 2024
UpdatedMay 1, 2026
André Eiras dos Santos

André Eiras dos Santos

Co-Founder, Sword Health

André Eiras dos Santos's Career

Sword Health
Sword Health

New York City, NY, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

André Eiras dos Santos's Career

Sword Health
Sword Health
Series B$323.2M7842015New York City, NY, US
Co-Founder

Recent news

Sword Health nabs $40M at $4B valuation, pushes IPO plans to at least 2028TechCrunch · 2025

Leadership at Sword Health

Virgílio BentoVirgílio BentoBoard Member
Todd CozzensTodd CozzensBoard Member
Márcio ColunasMárcio ColunasCo-Founder
Scott RotermundScott RotermundBoard Member

Similar to Sword Health

Comet HealthComet HealthPalo Alto, CA, USDigital Health, Therapyest. 2021Comet HealthPalo Alto, CA, US · est. 2021

Comet Healthcare: A digital platform for women's health, providing access to pelvic floor therapy.

Pre-Seed · $125k26
Harp HealthHarp HealthLondon, Greater London, GBDigital Health, Therapyest. 2022Harp HealthLondon, Greater London, GB · est. 2022

Harp Health: A digital healthcare provider offering accessible, effective therapy for women.

Pre-Seed · $120k5
Upswing HealthUpswing HealthStamford, CT, USDigital Clinic, Orthopedic Careest. 2019Upswing HealthStamford, CT, US · est. 2019

Upswing Health: Revolutionizing orthopedic care through a convenient digital clinic.

Seed · $5M35
Hinge HealthHinge HealthSan Francisco, CA, USDigital Health, MSK Clinicest. 2015Hinge HealthSan Francisco, CA, US · est. 2015

Hinge Health: A leading US-based digital MSK clinic reducing pain and surgeries via advanced tech.

Series E · $1B1.7k

André Eiras dos Santos's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to André Eiras dos Santos

Daniel CunhaDaniel CunhaCo-Founder · initial.vcAndy DrenickAndy DrenickFounder · Capital for FoundersEric LemoineEric LemoineCo-Founder · ExaraDaniel ViruezDaniel ViruezCo-Founder · Trade Up IncubatorDaniel KafeDaniel KafeCo-Founder · Expanding CapitalRyan JanssenRyan JanssenFounder · Ex Quanta